Elanco Adds Animal Health Veteran to Executive Committee
Retrieved on:
Monday, February 20, 2023
Health, Consumer, Agriculture, Pets, Natural Resources, Veterinary, ELAN, Marketing management, Boehringer Ingelheim, Marketing, NYSE, Western Sydney University, Acquisition, Reg Bettington, Livestock, University, Novartis, Commercial Operating System, Macquarie Graduate School of Management, Growth, Poultry, Management, Pig, Elanco, Zoetis, Cattle
Elanco Animal Health (NYSE: ELAN) announced today the appointment of Tim Bettington as the company’s executive vice president Corporate Strategy and Market Development.
Key Points:
- Elanco Animal Health (NYSE: ELAN) announced today the appointment of Tim Bettington as the company’s executive vice president Corporate Strategy and Market Development.
- Tim has built some of the industry’s most successful portfolios and overseen some of the most significant commercial businesses in animal health.
- Prior to Zoetis, he served as North American Region Head of Commercial Operations for Boehringer Ingelheim’s animal health business.
- In roles at Zoetis, Boehringer Ingelheim and Novartis Animal Health, Bettington developed deep expertise in sales excellence, product launch, strategy and business integration.